Can we discontinue synthetic disease-Modifying anti-Rheumatic drugs in rheumatoid arthritis?

Ian C. Scott, Gabrielle H. Kingsley, David Scott*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Can we discontinue synthetic disease-Modifying anti-Rheumatic drugs in rheumatoid arthritis?'. Together they form a unique fingerprint.

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science